Update on risk stratification and treatment of newly diagnosed multiple myeloma.

International journal of hematology

Volumn 94, Issue 4, 2011, Pages 310-320

  Kapoor, Prashant ^a   Rajkumar, S Vincent ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; MULTIPLE MYELOMA; PATHOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MULTIPLE MYELOMA; PROGNOSIS; RISK ASSESSMENT;

EID: 85027950818     PISSN: None     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0947-z     Document Type: Review

References (0)